Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

Yong Zhang, Meirong Huo, Jianping Zhou et al. · Computer Methods and Programs in Biomedicine · 2010 · 2.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +7

<i>Withania somnifera</i> reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver

Neha Sehgal, Alok Gupta, Rupanagudi Khader Valli et al. · Proceedings of the National Academy of Sciences · 2012 · 383 citations · Full text

Medicine, Neurobiology, Neuroscience +17

Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation

Jose Thaiparambil, Laura Bender, Thota Ganesh et al. · International Journal of Cancer · 2011 · 285 citations · Full text

Medicine, Cell Biology, Pharmacology +14

Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

Muzamil Ahmad, Sofiyan Saleem, Abdullah Shafique Ahmad et al. · Human & Experimental Toxicology · 2005 · 222 citations

Medicine, Neuroscience, Pharmacology +17

Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera Dunal. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum

Hisashi Matsuda, Toshiyuki Murakami, Akinobu Kishi et al. · Bioorganic & Medicinal Chemistry · 2001 · 219 citations

Life Sciences, Botany, Pharmacology +8